Postmarketing Surveillance of the Safety and Effectiveness of Metreleptin in Patients with Lipodystrophy in Japan
Metreleptin treatment was generally well tolerated in patients with generalized and partial lipodystrophy and lowered HbA1c and triglycerides in those with generalized lipodystrophy. This surveillance demonstrated for the first time the long-term safety in the real world and the effectiveness in patients who used the medication correctly.
Authors
- Ken Ebihara (ORCID: https://orcid.org/0000-0001-8938-0617)
- Tomohisa Hata
- Makiko Miyano
- Yumi Sato
Institutions
- Jichi Medical University (JP)
- Shionogi (Japan) (JP)
- Futaba (Japan) (JP)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1210/jendso/bvaf216
- Primary Topic
- Nuclear Structure and Function
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shionogi